{"title":"30 years of Nature Biotechnology","authors":"","doi":"10.1038/s41587-026-03073-9","DOIUrl":"10.1038/s41587-026-03073-9","url":null,"abstract":"Over the last 30 years, biotechnology has been driven by the genome sequencing revolution. For the next decade, it will be artificial intelligence that leads the charge in translating the biological complexity that results from these data.","PeriodicalId":19084,"journal":{"name":"Nature biotechnology","volume":"44 3","pages":"329-330"},"PeriodicalIF":41.7,"publicationDate":"2026-03-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.nature.comhttps://www.nature.com/articles/s41587-026-03073-9.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147474516","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Biotech news from around the world","authors":"","doi":"10.1038/s41587-026-03063-x","DOIUrl":"10.1038/s41587-026-03063-x","url":null,"abstract":"","PeriodicalId":19084,"journal":{"name":"Nature biotechnology","volume":"44 3","pages":"338-338"},"PeriodicalIF":41.7,"publicationDate":"2026-03-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147474605","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"AI turbocharges antibody hunt for binders with drug-like qualities","authors":"Andrew Marshall","doi":"10.1038/s41587-026-03048-w","DOIUrl":"10.1038/s41587-026-03048-w","url":null,"abstract":"Startups are providing tantalizing glimpses of AI-assisted antibody discovery and claiming game-changing potential, even as new models remain hidden and industry awaits full disclosure and benchmarking.","PeriodicalId":19084,"journal":{"name":"Nature biotechnology","volume":"44 3","pages":"334-337"},"PeriodicalIF":41.7,"publicationDate":"2026-03-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.nature.comhttps://www.nature.com/articles/s41587-026-03048-w.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147471392","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"A logic-gated trispecific engager enhances macrophage killing of cancer cells in solid tumors.","authors":"Xiaotian Zhao,Weiqiang Jing,Ganyu Wang,Zhanyan Liu,Xinxin Xu,Maosen Han,Zhipeng Fu,Yulin Zhang,Zuolin Zheng,Jing Zhang,Longyu Bo,Xianghui Dong,Caiping Li,Yanhua Sun,Junfeng Zhang,Fabao Zhao,Nianzeng Xing,Kun Zhao,Xinyi Jiang","doi":"10.1038/s41587-026-03057-9","DOIUrl":"https://doi.org/10.1038/s41587-026-03057-9","url":null,"abstract":"The antitumor efficacy of immune cell engagers that bind two targets on the same immune cell is limited by structural constraints, leading to incomplete coengagement and uncoordinated signaling. Here, we develop a trispecific macrophage engager (TrME) that both activates the prophagocytic receptor lipoprotein receptor-related protein 1 (LRP1) and blocks the antiphagocytic receptor signal regulatory protein alpha (SIRPα). This 'activate and block' AND logic gate, when coupled to a tumor-targeting moiety, enables coordinated signaling that enhances macrophage cytotoxicity against solid tumors. The TrME tandemly links monovalent LRP1 activator calreticulin, anti-SIRPα scFv and a tumor-associated antigen (TAA)-targeting arm through flexible linkers. Computational modeling and screening of tandem constructs revealed an optimal conformation for robust cis-targeting, allowing logic-gated control of ratiometric prophagocytic and antiphagocytic signaling. In situ generation of TrME by delivering mRNA encoding TAA-targeting TrME through an optimized lipid nanoparticle system activates macrophages and induces antitumor responses, significantly inhibiting tumor growth and prolonging survival in multiple solid tumor mouse models.","PeriodicalId":19084,"journal":{"name":"Nature biotechnology","volume":"95 1","pages":""},"PeriodicalIF":46.9,"publicationDate":"2026-03-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147446880","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Moon-Ju Kim,José A Lasalde-Ramírez,Wenzheng Heng,Wei Gao
{"title":"Biomolecular profiling for noninvasive health monitoring.","authors":"Moon-Ju Kim,José A Lasalde-Ramírez,Wenzheng Heng,Wei Gao","doi":"10.1038/s41587-026-03050-2","DOIUrl":"https://doi.org/10.1038/s41587-026-03050-2","url":null,"abstract":"Biomolecular profiling offers a powerful lens into human physiology, yet current diagnostics often rely on invasive sampling and delayed, centralized analysis. Advances in mass spectrometry (MS), particularly untargeted metabolomics and proteomics, have expanded molecular access to noninvasive biofluids such as sweat, saliva, tears and interstitial fluid, revealing dynamic biomarkers linked to both chronic and acute conditions. In parallel, wearable biosensors enable real-time, on-body chemical sensing, but remain limited to a narrow panel of predefined analytes. This Review highlights how MS-based molecular discovery and wearable sensing serve as complementary approaches-MS enabling high-dimensional untargeted profiling and wearables delivering longitudinal real-time data-and also discusses how their bidirectional integration and co-evolution open new possibilities for personalized noninvasive health monitoring. We discuss advances in sampling strategies, sensing modalities and system integration, and outline criteria for identifying biomarkers amenable to sensor translation. By uniting untargeted discovery with real-world deployment, this convergence shifts personalized noninvasive healthcare from episodic diagnostics to continuous, context-aware monitoring.","PeriodicalId":19084,"journal":{"name":"Nature biotechnology","volume":"33 1","pages":""},"PeriodicalIF":46.9,"publicationDate":"2026-03-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147439438","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Quantifying endosomal escape in vivo to guide lipid nanoparticle design.","authors":"Zhengwei Liu,Yizhou Dong","doi":"10.1038/s41587-026-03047-x","DOIUrl":"https://doi.org/10.1038/s41587-026-03047-x","url":null,"abstract":"","PeriodicalId":19084,"journal":{"name":"Nature biotechnology","volume":"31 1","pages":""},"PeriodicalIF":46.9,"publicationDate":"2026-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147393854","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Antony Jozić,Chloé Le Roux,Jeonghwan Kim,Mathieu Berchel,Deepak Kumar Sahel,Emily K Bodi,Michelle Palumbo,Aishwarya Vasudevan,Namratha Turuvekere Vittala Murthy,Yulia Eygeris,Milan Gautam,Elissa Bloom,Anthony P Barnes,Paul-Alain Jaffrès,Gaurav Sahay
{"title":"In vivo endosomal escape assay identifies mechanisms for efficient hepatic LNP delivery.","authors":"Antony Jozić,Chloé Le Roux,Jeonghwan Kim,Mathieu Berchel,Deepak Kumar Sahel,Emily K Bodi,Michelle Palumbo,Aishwarya Vasudevan,Namratha Turuvekere Vittala Murthy,Yulia Eygeris,Milan Gautam,Elissa Bloom,Anthony P Barnes,Paul-Alain Jaffrès,Gaurav Sahay","doi":"10.1038/s41587-026-03022-6","DOIUrl":"https://doi.org/10.1038/s41587-026-03022-6","url":null,"abstract":"Endosomal escape is a central barrier to efficient nucleic acid delivery by lipid nanoparticles (LNPs) and remains challenging to quantify in vivo. We report a library of branched ionizable phospholipids that markedly enhance messenger RNA delivery to the liver. The lead candidate BiP-20 outperformed the clinical benchmark LP01 by eightfold for CRISPR-Cas9 editing of the TTR gene at low dose with rapid pharmacokinetics. To quantify the endosomal escape kinetics of BiP-20, we used LysoTag mice, which allow immunoisolation of liver lysosomes, and our Lysosomal Barcoding method, finding that ~8% of BiP-20 LNPs reach the cytosol within 30 min of administration. Lysosomal proteomics revealed mechanistic regulators of escape and BiP-20-induced alterations in endosomal maturation and recycling pathways. Loss of Rab7, a mediator of late endosomal maturation, increased LNP escape. These findings provide a potent class of ionizable lipids for RNA delivery, a method to quantify endosomal escape in vivo, and mechanistic insight into the endolysosomal determinants of LNP trafficking.","PeriodicalId":19084,"journal":{"name":"Nature biotechnology","volume":"30 1","pages":""},"PeriodicalIF":46.9,"publicationDate":"2026-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147393855","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Brittney W Thornton,Rachel F Weissman,Jorge E Rodriguez,Ryan V Tran,Brenda T Duong,Cynthia I Terrace,Ugrappa Nagalakshmi,George Austin,Evan D Groover,Flora Zhiqi Wang,Jung-Un Park,Viktoriya Georgieva,Julia Tartaglia,Myeong-Je Cho,Savithramma P Dinesh-Kumar,Jennifer A Doudna,David F Savage
{"title":"Engineered TnpB genome editors for plants and human cells identified by ribonucleoprotein mutational scanning.","authors":"Brittney W Thornton,Rachel F Weissman,Jorge E Rodriguez,Ryan V Tran,Brenda T Duong,Cynthia I Terrace,Ugrappa Nagalakshmi,George Austin,Evan D Groover,Flora Zhiqi Wang,Jung-Un Park,Viktoriya Georgieva,Julia Tartaglia,Myeong-Je Cho,Savithramma P Dinesh-Kumar,Jennifer A Doudna,David F Savage","doi":"10.1038/s41587-026-03059-7","DOIUrl":"https://doi.org/10.1038/s41587-026-03059-7","url":null,"abstract":"TnpB is a diverse family of RNA-guided endonucleases associated with prokaryotic transposons. Because of their small size and putative evolutionary relationship to CRISPR-Cas12, TnpB enzymes hold great potential for genome editing. However, most TnpBs lack robust gene-editing activity. Here, we mapped comprehensive sequence-function landscapes of a TnpB ribonucleoprotein using deep mutational scanning and we discovered activating mutations in both the RNA and the protein. Leveraging the protein's mutational landscape, we constructed a combinatorial library of activating mutations, from which we identified two enhanced TnpB variants. These variants increased editing in human cells, Nicotania benthamiana, pepper and rice. While editing efficiencies varied by target site, engineered variants achieved up to 55% insertion and deletion frequencies (a 50-fold increase over wild type) in N. benthamiana, surpassing ISYmu1 (<7%), AsCas12f-HKRA (<9%) and other compact editors. These findings highlight elements critical for regulating TnpB endonuclease activity and demonstrate latent activity accessible through mutation.","PeriodicalId":19084,"journal":{"name":"Nature biotechnology","volume":"9 1","pages":""},"PeriodicalIF":46.9,"publicationDate":"2026-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147393852","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"The promises and challenges of neoantigen cancer vaccines.","authors":"Patrick A Ott","doi":"10.1038/s41587-026-03018-2","DOIUrl":"https://doi.org/10.1038/s41587-026-03018-2","url":null,"abstract":"Transformational advances in genomic sequencing capabilities, vastly improved HLA class I epitope prediction algorithms and powerful delivery platforms have facilitated the clinical development of vaccines targeting neoantigens encoded by tumor mutations. Early clinical trials indicate that vaccination against neoantigens can induce robust and durable T cell immunity that may persist for decades. mRNA vaccines, originally developed for cancer applications, have demonstrated considerable promise due to their efficacy and scalable production, as evidenced during the SARS-CoV-2 pandemic. However, the optimal cancer vaccine platform and delivery strategy is not yet known, as current approaches have not been compared head-to-head and substantial technological advances to improve immunogenicity and potentially clinical efficacy are achievable. For example, lipid-based formulations, while necessary for the effective delivery of mRNA vaccines, may also improve the immunogenicity of peptides and other delivery strategies. Here we review the current state of neoantigen vaccines in the clinic and highlight emerging opportunities for advancement in the field.","PeriodicalId":19084,"journal":{"name":"Nature biotechnology","volume":"188 1","pages":""},"PeriodicalIF":46.9,"publicationDate":"2026-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147383364","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}